In this episode of the Health Further podcast, Vic interviews Josh Eckelberry, a seasoned venture capitalist and Principal at Solas BioVentures, a life sciences venture capital firm. Josh brings a wealth of knowledge in healthcare innovation, particularly in heart health and cutting-edge cardiac technologies. With a focus on breakthrough medical devices, novel pharmaceuticals, and AI-driven diagnostic tools, Josh shares his insights on the future of healthcare and heart disease treatment. From discussing his journey into venture capital to highlighting the latest advancements in cardiac care, this episode is packed with valuable insights for anyone interested in health tech, medical innovations, and investment in healthcare startups.

Solas BioVentures website: https://www.solasbio.com/

Josh Eckelberry on LinkedIn

Innovation videos used in the show

Intershunt: YouTube

Basking Biosciences: YouTube

Vektor Medical: YouTube

00:00:00 - Intro

00:00:17 - Introduction of Josh Eckelberry

00:01:07 - Overview of Cardiac Innovation Pipeline

00:01:50 - Diagnostic Tools, Treatments, and New Technologies

00:02:00 - Josh Eckelberry's Background and Journey into Venture Capital

00:04:00 - Role and Focus of Solas BioVentures

00:06:00 - Investment in Cardiac Care and Life Sciences

00:07:12 - Types of Innovations: Molecules, Devices, and Diagnostics

00:14:05 - Introduction of InterShunt Technology

00:19:00 - Commercialization and Clinical Trials of InterShunt

00:21:00 - Introduction of Basking Biosciences and Stroke Treatment Innovation

00:24:00 - Basking Biosciences' Aptamer Technology

00:32:00 - Introduction of Vektor Medical's AI-Based Cardiac Mapping

00:36:00 - FDA Clearance and Adoption of Vektor Medical's Technology

00:38:00 - The Future of Cardiac Innovation and Healthcare Technology

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK